DYNE THERAPEUTICS INC. - COMMON STOCK
32.58
04-October-24 15:59:59
15 minutes delayed
Stocks
-0.97
-2.89%
Today's range
32.39 - 34.00
ISIN
N/A
Source
NASDAQ
-
Dyne Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights
02 May 2022 16:05:01 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights
10 Mar 2022 07:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Appoints Carlo Incerti, M.D., to its Board of Directors
03 Mar 2022 07:30:00 By Nasdaq GlobeNewswire
-
18 Jan 2022 08:00:01 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
05 Jan 2022 07:30:00 By Nasdaq GlobeNewswire
-
02 Dec 2021 08:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports Third Quarter 2021 Financial Results and Business Highlights
04 Nov 2021 07:30:01 By Nasdaq GlobeNewswire
-
13 Oct 2021 07:45:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Host Virtual Research and Development Day on Wednesday, October 13, 2021
28 Sep 2021 07:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Chardan’s Virtual 5th Annual Genetic Medicines Conference
27 Sep 2021 07:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports Second Quarter 2021 Financial Results and Business Highlights
05 Aug 2021 07:30:01 By Nasdaq GlobeNewswire
-
25 Jun 2021 07:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Chief Scientific Officer Transition
02 Jun 2021 16:05:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Jefferies Virtual Healthcare Conference
26 May 2021 07:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights
06 May 2021 07:29:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights
04 Mar 2021 07:35:00 By Nasdaq GlobeNewswire